NIH Locks Doors on Grant Reviews to Guard Secrets
Published Date: 3/7/2025
Notice
Summary
The NIH’s Center for Scientific Review is holding several closed virtual meetings in late March 2025 to review and evaluate grant applications related to infectious diseases and immunology. These meetings protect sensitive info like personal data and trade secrets, ensuring privacy and fairness. Researchers applying for grants in these areas should note the dates and prepare for funding decisions that could impact their projects.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed Virtual Grant Review Meetings
The NIH Center for Scientific Review will hold closed virtual meetings March 25-28, 2025 to review and evaluate grant applications for infectious diseases and immunology. The specific study sections named include Viral Dynamics and Transmission; HIV Coinfections and HIV Associated Cancers; HIV Comorbidities and Clinical Studies; and HIV Immunopathogenesis and Vaccine Development.
Confidentiality of Applicant Information
The meetings are closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property such as patentable material, and personal information about individuals associated with the grant applications. If you applied to these study sections, your trade secrets and personal information are explicitly protected during the review process.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2025-03717, Information Collection Being Submitted for Review and Approval to Office of Management and Budget
The FCC is asking the public and other agencies to help reduce paperwork, especially for small businesses with fewer than 25 employees. They want to make sure all info collections have a valid approval number to avoid penalties. This is a chance to shape how the FCC collects info and cut down on hassle, with no extra costs or deadlines yet announced.
Next: 2025-03720, Submission for OMB Review; Comment Request; Extension: Form SE
The Securities and Exchange Commission wants to keep using Form SE, which helps people who file documents electronically but need to submit some parts on paper. This form is used by a few filers each year and takes just a tiny bit of time to complete. If you have thoughts on making this process easier or clearer, you can share your comments by April 7, 2025.